SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Essential Therapeutics (ETRX) formerly Microcide (MCDE
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: LLCF who wrote (224)11/11/1999 1:51:00 PM
From: scaram(o)uche  Read Replies (1) of 415
 
That's not the impression that I got. I think that the author was trying to say that the "trigger" for a cancer could be a bacterial infection. I'll agree with that. Again, effective treatment there probably wouldn't require a new antibiotic, and I therefore don't see the relevance for MCDE, CBST, etc.

However, much of what the author said focused on viruses that have already been ass'd with malignancy. Suggest starting with Cantab, if you want to start exploring those avenues..... you want to look not only at HPV projects, but also at various herpes viruses. I guess that you're correct in a sense, that the MCDE spinoff, Iconix, is a play here.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News